An official said the effect of any changes on the immune effect of the vaccine was not detected.
Beijing:
There is no indication that new coronavirus modifications will affect the immunosuppressive effect of a vaccine that China has just approved for public use, a disease control official reported Friday.
The bullet by a relative of state-backed Sinopharm company was agreed Thursday, the day after news of the first case brought into China of various spreads spread in Britain.
“There is no need to panic,” Xu Wenbo, an official at the Chinese Center for Disease Control and Prevention (CDC), told state TV.
“There is no obvious change in the mutated change, compared to previous mutated changes …. so far in its ability to cause disease,” he said.
He said the effect of any changes on the immune effect of the vaccine was not detected.
The variant named by British scientists “VUI – 202012/01” involves a genetic mutation in the protein “spike”, which could theoretically facilitate the release of COVID-19.
Xu said a mutation in the virus’s protein would not affect the sensitivity of most COVID-19 tests done in China that target the virus’s nuclear acids, which carry genetic information.
(This story was not edited by NDTV staff and is automatically extracted from syndicated feedings.)